Equities
  • Price (EUR)65.15
  • Today's Change0.47 / 0.73%
  • Shares traded0.00
  • 1 Year change-5.33%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Fortive Corporation is a provider of essential technologies for connected workflow solutions across a range of end-markets. It operates through three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. Intelligent Operating Solutions segment offers various Products and services under a range of brands, including Accruent, Fluke, Gordian, Industrial Scientific, Intelex, Pruftechnik, and Servicechannel. Precision Technologies segment provides electrical test and measurement instruments and services, energetic material devices, and a range of sensor and control system solutions. Advanced Healthcare Solutions segment provides hardware, consumables, software and services that helps in the customers' workflows, including instrument sterilization and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, end-to-end clinical productivity solutions and asset

  • Revenue in USD (TTM)5.67bn
  • Net income in USD697.40m
  • Incorporated2015
  • Employees18.00k
  • Location
    Fortive Corp6920 Seaway BlvdEVERETT 98203-5829United StatesUSA
  • Phone+1 (425) 446-5000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.fortive.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
FTV:NYQ since
announced
Transaction
value
ProVation Medical IncDeal completed03 Dec 202103 Dec 2021Deal completed-8.32%1.43bn
Data delayed at least 15 minutes, as of Nov 25 2022 18:10 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.